Form 4: iRhythm EVP Sells Shares Under 10b5-1 Plan
Insider Transaction Report
iRhythm Holdings, Inc. EVP Mervin Smith sold 732 shares of common stock for $140.91 per share as part of a pre-arranged trading plan.
Summary
- EVP Strategic Business Operations, Mervin Smith, of iRhythm Holdings, Inc. (IRTC) reported a sale of common stock.
- The transaction involved the disposition of 732 shares of common stock.
- The shares were sold at a price of $140.91 per share.
- The sale was executed on February 24, 2026.
- Following the transaction, Mervin Smith directly beneficially owns 15,106 shares of common stock.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan established on November 19, 2025.
- A holding company reorganization occurred on January 12, 2026, where iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc., with a one-for-one conversion of securities.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a pre-scheduled transaction under a 10b5-1 plan, which typically indicates personal financial planning rather than a reaction to new company-specific information.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that routine insider sales executed under a Rule 10b5-1 plan are common practice for executives to manage personal finances and diversify holdings without signaling a change in their outlook on the company's prospects. This type of transaction is generally viewed as less impactful than unscheduled sales.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Holding Company Reorganization | iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc. pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934. All outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one-for-one basis. | 2026-01-12 | This reorganization ensures continuity of security holder interests and simplifies the corporate structure by establishing a holding company framework. |
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a pre-scheduled insider sale, not indicative of new company performance.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 2025-11-19 | Rule 10b5-1 trading plan established by Mervin Smith. |
| 2026-01-12 | iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc. via a holding company reorganization. |
| 2026-02-24 | Date of common stock transaction by Mervin Smith. |
| 2026-02-25 | Date Form 4 was signed. |
Recommendation
holdThe reported insider sale by an EVP is a routine transaction executed under a pre-established 10b5-1 trading plan. Such sales are typically for personal financial management and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The holding company reorganization is also a structural change with no immediate impact on proportionate ownership. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.
Keywords
iRhythm Holdings, IRTC, Insider Trading, Form 4, Stock Sale, Mervin Smith, 10b5-1 Plan, Corporate Governance, Holding Company Reorganization
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.